Inflammatix

OverviewSuggest Edit

Inflammatix is a molecular diagnostics company. It develops tests for acute bacterial and viral infections, and sepsis based on patent-pending biomarkers, enabling healthcare teams to build a host response-based diagnostics pipeline. The company includes tests for tropical infections, autoimmune diseases, transplant rejection, and other conditions.
TypePrivate
Founded2016
HQBurlingame, CA, US
Websiteinflammatix.com
Employee Ratings4.9

Latest Updates

Employees (est.) (Oct 2021)107(+4%)
Cybersecurity ratingAMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Inflammatix

Oliver Liesenfeld

Oliver Liesenfeld

Chief Medical Officer
Ljubomir Buturovic

Ljubomir Buturovic

Vice President of Machine Learning
Joao Fonseca

Joao Fonseca

Chief Technology Officer
Purvesh Khatri

Purvesh Khatri

Co-Founder and Scientific Advisor
Steve Tablak

Steve Tablak

Director
Michael Rubin

Michael Rubin

Director
Show more

Inflammatix Office Locations

Inflammatix has an office in Burlingame
Burlingame, CA, US (HQ)
863 Mitten Rd #104
Show all (1)

Inflammatix Financials and Metrics

Summary Metrics

Founding Date

2016

Inflammatix total Funding

$33 m

Inflammatix latest funding size

$32 m

Time since last funding

2 years ago

Inflammatix investors

Inflammatix's latest funding round in January 2020 was reported to be $32 m. In total, Inflammatix has raised $33 m
Show all financial metrics

Inflammatix Cybersecurity Score

Cybersecurity ratingPremium dataset

A

93/100

SecurityScorecard logo

Inflammatix Online and Social Media Presence

Embed Graph

Inflammatix Blogs

Protected: Adaptive CV: An approach for faster cross validation and hyperparameter tuning- clone

This content is password protected. To view it please enter your password below: Password: The post Protected: Adaptive CV: An approach for faster cross validation and hyperparameter tuning- clone appeared first on Inflammatix.

Adaptive CV: An approach for faster cross validation and hyperparameter tuning

Adaptive CV: an approach for faster cross validation and hyperparameter tuning Introduction Identification of optimal hyperparameters is an integral component for building robust accurate machine learning models. Hyperparameters control various aspects of a classification model such as learning rate…

COVID-19 and Sepsis: Risk-Stratifying Patients Based on Their Immune Response

Host-response diagnostics that “read” the immune response can help clinicians make better, faster treatment decisions Even before the pandemic, about 15 million patients per year presented to US emergency rooms with suspected acute infections or sepsis. Physicians often struggle with rapid and accur…

(Sr) Clinical Research Associate (East Coast)

ABOUT THE COMPANY: Inflammatix, Inc. is a venture-backed diagnostics company bringing the power of precision medicine to the point of care.  We are building novel diagnostic, prognostic, and predictive HostDx™ tests that combine rapid detection of host mRNA panels with advanced machine learning and …

Clinical Trials Associate

ABOUT THE COMPANY: Inflammatix, Inc. is a venture-backed diagnostics company bringing the power of precision medicine to the point of care.  We are building novel diagnostic, prognostic, and predictive HostDx™ tests that combine rapid detection of host mRNA panels with advanced machine learning and …

New Technologies Can Step Up Fight Against Antimicrobial Resistance and Sepsis

Sepsis and antimicrobial resistance (AMR) account for growing numbers of deaths and healthcare costs worldwide. It is believed that sepsis causes over 5 million deaths annually. One report predicts that AMR could cause over 10 million deaths globally per year by 2050. Both sepsis and AMR in the clin…
Show more

Inflammatix Frequently Asked Questions

  • When was Inflammatix founded?

    Inflammatix was founded in 2016.

  • Who are Inflammatix key executives?

    Inflammatix's key executives are Oliver Liesenfeld, Ljubomir Buturovic and Joao Fonseca.

  • How many employees does Inflammatix have?

    Inflammatix has 107 employees.

  • Who are Inflammatix competitors?

    Competitors of Inflammatix include Miroculus, Alpha Imaging and Translate Bio.

  • Where is Inflammatix headquarters?

    Inflammatix headquarters is located at 863 Mitten Rd #104, Burlingame.

  • Where are Inflammatix offices?

    Inflammatix has an office in Burlingame.

  • How many offices does Inflammatix have?

    Inflammatix has 1 office.